Eli Lilly And Stock Performance
| LLY Stock | USD 1,010 13.70 1.34% |
The firm shows a Beta (market volatility) of 0.8, which means possible diversification benefits within a given portfolio. As returns on the market increase, Eli Lilly's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eli Lilly is expected to be smaller as well. At this point, Eli Lilly has a negative expected return of -0.0649%. Please make sure to confirm Eli Lilly's treynor ratio, as well as the relationship between the expected short fall and day median price , to decide if Eli Lilly performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, Eli Lilly is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (1.34) | Five Day Return (2.93) | Year To Date Return (6.56) | Ten Year Return 1.3 K | All Time Return 35.8 K |
Forward Dividend Yield 0.0062 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 6.23 | Dividend Date 2026-03-10 |
| Eli Lilly dividend paid on 10th of December 2025 | 12/10/2025 |
1 | Eli Lilly Stock Rebounds As Weight-Loss Drug Battle Continues | 01/23/2026 |
2 | How TrumpRx promises to cut drug prices -- and who actually benefits | 02/09/2026 |
3 | Eli Lilly Builds 1.5 Billion Pill Inventory | 02/13/2026 |
4 | Eli Lilly Reports Phase 3 Win for Retevmo in Early Lung Cancer | 02/17/2026 |
5 | Eli Lillys Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo | 02/18/2026 |
6 | Eli Lilly Expands Pipeline with Clazakizumab Agreement, Reuters Reports | 02/20/2026 |
| Begin Period Cash Flow | 3.3 B | |
| Total Cashflows From Investing Activities | -11 B |
Eli Lilly Relative Risk vs. Return Landscape
If you would invest 106,838 in Eli Lilly and on November 22, 2025 and sell it today you would lose (5,886) from holding Eli Lilly and or give up 5.51% of portfolio value over 90 days. Eli Lilly and is generating negative expected returns assuming volatility of 2.4619% on return distribution over 90 days investment horizon. In other words, 22% of stocks are less volatile than Eli, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Eli Lilly Target Price Odds to finish over Current Price
The tendency of Eli Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1,010 | 90 days | 1,010 | about 90.63 |
Based on a normal probability distribution, the odds of Eli Lilly to move above the current price in 90 days from now is about 90.63 (This Eli Lilly and probability density function shows the probability of Eli Stock to fall within a particular range of prices over 90 days) .
Eli Lilly Price Density |
| Price |
Predictive Modules for Eli Lilly
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eli Lilly. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Eli Lilly Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Eli Lilly is not an exception. The market had few large corrections towards the Eli Lilly's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Eli Lilly and, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Eli Lilly within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.06 | |
β | Beta against Dow Jones | 0.80 | |
σ | Overall volatility | 29.19 | |
Ir | Information ratio | -0.03 |
Eli Lilly Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Eli Lilly for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Eli Lilly can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Eli Lilly generated a negative expected return over the last 90 days | |
| Over 85.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Deutsche Bank Upgrades Merck to Buy, Sees Clear Path Beyond Keytruda Patent Cliff |
Eli Lilly Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Eli Stock often depends not only on the future outlook of the current and potential Eli Lilly's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eli Lilly's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 898 M | |
| Cash And Short Term Investments | 7.3 B |
Eli Lilly Fundamentals Growth
Eli Stock prices reflect investors' perceptions of the future prospects and financial health of Eli Lilly, and Eli Lilly fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Eli Stock performance.
| Return On Equity | 1.01 | ||||
| Return On Asset | 0.19 | ||||
| Profit Margin | 0.32 % | ||||
| Operating Margin | 0.45 % | ||||
| Current Valuation | 1 T | ||||
| Shares Outstanding | 943.36 M | ||||
| Price To Earning | 54.92 X | ||||
| Price To Book | 36.38 X | ||||
| Price To Sales | 14.61 X | ||||
| Revenue | 65.18 B | ||||
| Gross Profit | 54.13 B | ||||
| EBITDA | 27.94 B | ||||
| Net Income | 20.64 B | ||||
| Cash And Equivalents | 7.27 B | ||||
| Cash Per Share | 2.97 X | ||||
| Total Debt | 42.5 B | ||||
| Debt To Equity | 1.58 % | ||||
| Current Ratio | 1.13 X | ||||
| Book Value Per Share | 29.66 X | ||||
| Cash Flow From Operations | 16.81 B | ||||
| Earnings Per Share | 22.92 X | ||||
| Market Capitalization | 952.34 B | ||||
| Total Asset | 112.48 B | ||||
| Retained Earnings | 24.47 B | ||||
| Working Capital | 20.4 B | ||||
| Current Asset | 12.57 B | ||||
| Current Liabilities | 8.23 B | ||||
About Eli Lilly Performance
Evaluating Eli Lilly's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Eli Lilly has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Eli Lilly has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 474.87 | 498.62 | |
| Return On Tangible Assets | 0.21 | 0.14 | |
| Return On Capital Employed | 0.38 | 0.28 | |
| Return On Assets | 0.18 | 0.13 | |
| Return On Equity | 0.78 | 0.82 |
Things to note about Eli Lilly performance evaluation
Checking the ongoing alerts about Eli Lilly for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Eli Lilly help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Eli Lilly generated a negative expected return over the last 90 days | |
| Over 85.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Deutsche Bank Upgrades Merck to Buy, Sees Clear Path Beyond Keytruda Patent Cliff |
- Analyzing Eli Lilly's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Eli Lilly's stock is overvalued or undervalued compared to its peers.
- Examining Eli Lilly's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Eli Lilly's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Eli Lilly's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Eli Lilly's stock. These opinions can provide insight into Eli Lilly's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.